Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Serum
DISEASE(S): Duchenne Muscular Dystrophy
SUBMITTER: Tchilabalo ALAYI
LAB HEAD: Yetrib Hathout
PROVIDER: PXD013174 | Pride | 2021-01-30
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
QE003213TA.mzML | Mzml | |||
QE003213TA.mzid.gz | Mzid | |||
QE003213TA.pride.mgf.gz | Mgf | |||
QE003213TA.raw | Raw | |||
QE003214TA.mzML | Mzml |
Items per page: 5 1 - 5 of 288 |
Alayi Tchilabalo D TD Tawalbeh Shefa M SM Ogundele Michael M Smith Holly R HR Samsel Alison M AM Barbieri Marissa L ML Hathout Yetrib Y
ACS omega 20201006 41
Blood-accessible molecular biomarkers are becoming highly attractive tools to assess disease progression and response to therapies in Duchenne muscular dystrophy (DMD) especially in very young patients for whom other outcome measures remain subjective and challenging. In this study, we have standardized a highly specific and reproducible multiplexing mass spectrometry method using the tandem mass tag (TMT) strategy in combination with depletion of abundant proteins from serum and high-pH reverse ...[more]